Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record content, blocking access to trial details and related information.
    Difference
    19%
    Check dated 2026-09-22T22:08:40.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, representing a new release of the page. This may include minor updates or fixes to the page structure or metadata.
    Difference
    0.0%
    Check dated 2026-09-15T21:39:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision stamp (Revision: v3.6.6) was added, replacing the previous v3.6.5. This indicates a small, internal update to the page's platform without altering study details.
    Difference
    0.0%
    Check dated 2026-09-08T17:47:13.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added funding source information: '2018 ( U.S. NIH Grant/Contract )' appears under the study identifiers, clarifying NIH support for the trial. This provides context about who funded the study.
    Difference
    0.0%
    Check dated 2026-08-25T20:56:44.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing v3.6.4. This indicates a minor backend/UI update to the page without modifying its content.
    Difference
    0.0%
    Check dated 2026-08-11T22:32:15.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a routine system update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-21T22:37:14.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.